publication venue for
- Editorial overview: Special Issue on 'Chemogenetics and photopharmacology'.. 66. 2022
- Impact of currently used anti-diabetic drugs on myoendothelial communication. 2018
- Exploiting vita-PAMPs in vaccines. 2018
- Anaplastic lymphoma kinase inhibitors. 2015
- Gut microbiota and the role of probiotics in therapy. 2011
- Probiotics in functional gastrointestinal disorders: what are the facts? 2008
- Targeting the androgen receptor pathway in prostate cancer. 2008
- Therapeutic strategies for inhibiting oncogenic BRAF signaling. 2008
- Therapeutic applications of carbon monoxide in lung disease. 2006
- New insights into the pathogenesis and therapy of Behçet's disease. 2004
- Mutant genes responsible for Parkinson's disease. 2004
- Cyclooxygenase inhibitors: drugs for cancer prevention. 2003
- Uric acid and cardiovascular risk. 2002
- High-density lipoprotein cholesterol: an updated view. 2001
- Tapering biologic DMARDs in rheumatoid arthritis. 2022
- Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway. 2022
- Treatment advances in antiphospholipid syndrome: 2022 update. 2022
- Advances in tethered photopharmacology for precise optical control of signaling proteins. 2022
- Nuclear receptors in osteoclasts. 2020
- Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer. 2016
- Emerging targets in osteoarthritis therapy. 2015
- Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential. 2015
- Promising pharmacologic innovations in treating pulmonary fibrosis. 2006